VIAMET PHARMACEUTICALS
Viamet Pharmaceuticals discovers and develops "best-in-class" inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, their Metallophileâ„¢ Technology. Viamet's disruptive Metallophileâ„¢ technology is based on their world-class expertise in bioinorganic chemistry and metalloenzymes and allows them to identify validated targets with high therapeutic and commercial potential; leverage existing metalloenzyme inhibitors as the basis for Viamet's best-in-class analogs; and rapidly and cost-effectively generate best-in-class, patentable, small molecule compounds by optimizing the metal-binding component of existing inhibitors.
VIAMET PHARMACEUTICALS
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
2005-01-01
Address:
Morrisville, North Carolina, United States
Country:
United States
Website Url:
http://www.viamet.com
Total Employee:
11+
Status:
Closed
Contact:
(919) 467-8539
Email Addresses:
[email protected]
Total Funding:
120.2 M USD
Technology used in webpage:
Domain Not Resolving
Current Advisors List
Current Employees Featured
Founder
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Viamet Pharmaceuticals
Intersouth Partners
Intersouth Partners investment in Series D - Viamet Pharmaceuticals
Novartis Venture Fund
Novartis Venture Fund investment in Series D - Viamet Pharmaceuticals
Astellas Venture Management
Astellas Venture Management investment in Series D - Viamet Pharmaceuticals
Lilly Ventures
Lilly Ventures investment in Series D - Viamet Pharmaceuticals
Hatteras Venture Partners
Hatteras Venture Partners investment in Series D - Viamet Pharmaceuticals
Lurie Investment Fund
Lurie Investment Fund investment in Series B - Viamet Pharmaceuticals
Lilly Ventures
Lilly Ventures investment in Series B - Viamet Pharmaceuticals
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Viamet Pharmaceuticals
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - Viamet Pharmaceuticals
Official Site Inspections
http://www.viamet.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
